Aytu BioPharma, Inc., a pharmaceutical company focused on developing and commercializing novel therapeutics, reported financial results for its fiscal 2022 third quarter, ended March 31, 2022 and outlined its key strategic priorities.
May 16, 2022
· 15 min read